Sort   by:  
 Page size 
MetabolomicsMetabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival

The spread of cancer to bone is invariably fatal, with complex cross-talk between tumor cells and the bone microenvironment responsible for driving disease progression. By combining in silico analysis of patient datasets with metabolomic profiling of prostate cancer cells cultured with bone cells...

2024-08-19 | MTBLS3973 | MetaboLights
GenomicsIntegrated genomic characterization of IDH1 mutant Glioma malignant progression
Gliomas represent approximately 30% of all central nervous system tumors, and 80% of malignant brain tumors. To understand the molecular mechanisms underlying the malignant progression of low-grade Isocitrate Dehydrogenase 1 (IDH1) mutant gliomas, we studied paired tumor samples from 41 patients, co...
EGAS00001001588 | EGA
UnknownThe frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study.
Not available
S-EPMC10560724 | biostudies-literature
UnknownCyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices.
Not available
S-EPMC11895381 | biostudies-literature
Sort   by:  
 Page size